TRAF2

TNF receptor-associated factor 2 · Q12933 · TRAF2 on Sugi Atlas →

0 patent compounds predicted against TRAF2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TRAF2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer PHASE4UNKNOWN
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
Clinical Evaluation of the Effect of Metformin in Sepsis PHASE3UNKNOWN
TNFSF11 Inhibition and Fertility: a Prospective Study PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction PHASE2COMPLETED
A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma PHASE1COMPLETED
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE PHASE1RECRUITING
Bioequivalence Study of Tacrolimus in Healthy Volunteers PHASE1COMPLETED
Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors PHASE1COMPLETED
Concentration and Activity of Lapatinib in Vestibular Schwannomas EARLY_PHASE1COMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients. nanCOMPLETED
MicroRNAs and Cytokines in Peri-Implantitis Tissue nanUNKNOWN
Novel Biomarkers in Inflammatory Bowel Disease nanCOMPLETED
Functional Implications of TNF nanCOMPLETED
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection nanRECRUITING
TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP) nanNOT_YET_RECRUITING
TL1A Expression in Psoriatic Skin nanUNKNOWN
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis nanUNKNOWN
Adipocytokines in Endometrial Cancer nanCOMPLETED
RORC Genetic Polymorphism of Rheumatoid Arthritis nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Effect of Smoking on Periodontal Therapy in Periodontitis nanCOMPLETED
The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty nanUNKNOWN
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea nanRECRUITING
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Multiple Sclerosis nanUNKNOWN
DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA nanCOMPLETED
Immune Cell Response to Stimuli nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TRAF2 binder may also engage these)

ProteinNameSimilarity
P39429 1.000 P39429 →
P70191 0.993 P70191 →
Q13114 0.988 Q13114 →
Q6IWL4 0.985 Q6IWL4 →
O00463 0.983 O00463 →
Q9BUZ4 0.983 Q9BUZ4 →
Q60803 0.983 Q60803 →
Q28DL4 0.980 Q28DL4 →
Q61382 0.980 Q61382 →
Q91ZY8 0.979 Q91ZY8 →
P70196 0.979 P70196 →
Q9JI90 0.979 Q9JI90 →
P39428 0.978 P39428 →
Q6J1I8 0.978 Q6J1I8 →
F1RB95 0.977 F1RB95 →
Q60629 0.977 Q60629 →
Q9C026 0.977 Q9C026 →
Q6J2U6 0.976 Q6J2U6 →
Q6DJN2 0.976 Q6DJN2 →
Q804S5 0.976 Q804S5 →
RNF114 E3 ubiquitin-protein ligase RNF114 0.976 landscape →
Q6GNY1 0.976 Q6GNY1 →
Q6J212 0.975 Q6J212 →
Q29RQ5 0.975 Q29RQ5 →
M9MRI4 0.975 M9MRI4 →
Q8R516 0.974 Q8R516 →
Q8BGX0 0.974 Q8BGX0 →
Q5ZJM3 0.974 Q5ZJM3 →
Q5ZIJ9 0.974 Q5ZIJ9 →
Q8W468 0.974 Q8W468 →